AMSTERDAM, April 18, 2012 /CNW/ - Leading events organiser UBM Live has revealed further details of the newest event to join the global UBM Pharma Portfolio, CPhI Southeast Asia (SEA) 2012. Set to debut from 10-12 May 2012 at the Jakarta International Expo in Indonesia, CPhI SEA is the first trade show and exhibition of its kind to be dedicated to the pharmaceutical ingredient sector in the ASEAN region.
CPhI SEA will provide a meeting place for pharmaceutical professionals to expand their networks in the dynamic ASEAN market. Several high profile international pharma firms will exhibit, including Boehringer Ingelheim, Phapros, and the Mensa Group, along with exhibitors in the steadily growing natural extract sector such as Javaplant and Semarang Herbal. The event will also have support from international organizations Pharmexcil India, the China Council for the Promotion of International Trade (CCPIT) and the China Chamber of Commerce for Import & Export of Medicine and Health Products (CCCMHPIE). To learn more about the line-up, or to register for CPhI SEA, please visit: www.cphi-sea.com/
"The ASEAN pharma market represents huge potential for companies looking to expand operations. Notably, there is strong interest in R&D for generics in this region, which are expected to grow from 8.3% of the total market in 2010 to 12.8% by 2015, when they will be worth USD 12.3bn(1)," noted Andrew Pert, UBM Live Regional Director. He went on to comment that, "Beyond generics, the Indonesian Pharmaceutical Association, GP Farmasi, forecasts a market value of USD 4.9 billion in 2012 which represents an increase of 10-12% year over year(1). The growth rate is phenomenal and UBM Live is pleased to debut CPhI Southeast Asia in 2012 to support this emerging market."
The ASEAN pharmaceutical market has experienced strong growth and a rise in the regional standard of living which have made it a region of interest for companies looking to explore new business opportunities. The growth has also impacted the import value of pharmaceutical raw materials which is projected to reach up to USD 1.39 billion this year, about 11-15 percent higher than last year, according to a recent article in Indonesia Finance Today(1).
CPhI Southeast Asia promises to offer direct access to the Indonesian and ASEAN pharmaceutical industry and provide attendees with the opportunity to gather information firsthand. The event will feature a zoned format for ease of navigation, with zones for APIs, intermediates, natural extracts, biopharmaceuticals, custom manufacturing, fine chemicals, excipients/formulations, and a general zone for the cross over between the different zones. There will also be international pavilions to cater to the diverse range of guests from across the globe. Specifically, the China and India Pavilions will offer contact with partners in the greater Asia pharmaceutical market.
To learn more about the new CPhI SEA event, or to register, please visit: www.cphi-sea.com/.
The UBM Live annual schedule of Pharmaceutical events also includes ICSE USA (22-23 May, 2012 at the Pennsylvania Convention Centre in Philadelphia, PA), CPhI, ICSE, P-MEC InnoPack and BioPh China (26-28 June, 2012 at the SNIEC in Shanghai, China), CPhI, ICSE and BioPh South America (21-23 August, 2012 at the Transamerica Expo Center in Sao Paulo, Brazil), CPhI Worldwide, ICSE, P-MEC and InnoPack (9-11 October, 2012 at the Feria de Madrid, Spain), CPhI and P-MEC India (21-23 November, 2012 at the Bombay Exhibition Centre in Mumbai) and CPhI, ICSE, P-MEC and Pharmatec Japan (24-26 April, 2013 at the Tokyo Big Sight Exhibition Centre in Japan).
Notes for Editors:
UBM Live is a division of UBM Plc (LSE: UBM) a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in more than 30 countries and are organized into specialist teams that serve their business communities helping them excel in their market by working effectively and efficiently. For more information, go to www.ubmlive.com.
SOURCE UBM Live
For further information:
Media Enquiries: Impress Labs, Global (excl. North America): Richard Kerns, + 44 161 728 5880, [email protected], or North America: Beth Willers, +1-503-928-7828, [email protected], or Company Enquiries: Liz Wakefield, Marketing Director, UBM Live, +31 (0) 20 40 99 577